Currently the government pays more attention to the development of high technologies in medicine.

Radiation diagnostics and therapy is a medical direction dynamically developing in the whole world. Its new technologies make it possible, for instance, to research and treat oncological diseases with application of isotopes with no radical surgery required.
In Russia such direction still falls behind world growth indicators, but there has been a tendency to reduce such gap demonstrated within recent years.

BEBIG Company was found in July, 2004, in order to bring high-tech and innovation oncological diseases treatment methods in Russian market. Such direction has become a priority for further development of the Company.

Since 2006, the Company management’s main task has been promotion of brachytherapy method in Russia as a high-tech prostate gland cancer treatment method. The method has proven its high efficiency at numerous health institutions of Russia. By now, already 17 health institutions apply brachytherapy as a treatment method throughout Russia.

Based on this, there is an issue of launching a domestic line of iodine-125-based microsources production used for brachytherapy, earlier bought abroad, arisen.

Read more

News

February 25, 2010

BEBIG Company together with German company IBT Bebig Group has arranged educational Workshop “Implantation of Permanent IsoCord Implants for Treatment of Patients Suffering from Prostate Gland Cancer” for doctors applying brachytherapy. The Workshop was held in Berlin (Germany), on the basis of Clinic AOZ Ullesteinhaus and IBT Bebig from February 17 to February 21, 2010, 21 people took part in the workshop.

Education included both theoretical training on implantation of sources and dosimetry, and practice training, including presence at operations, performed by doctors Thomas Henkel and Frank Kahmann, well known in this field of medicine.

This event was arranged shortly before the launch of a domestic line of iodibe-125 microsources production, required for brachytherapy of prostate gland cancer.
The project of domestic microsources production is implemented with the support and funding of GC Rosnano.

We thank all doctors, who managed to take part in the workshop! We hope that training was useful and you will be able to apply your new practice skills in your work.

We are also thankful to our German partners – IBT Bebig Group company for arrangement of the workshop and warm welcome.

Back to newsline